Daniel Geiger is a lawyer, specialist lawyer for medical law and business mediator. He is a partner in the law firm Geiger, Nitz and Daunderer (GND GEIGER | NITZ | DAUNDERER PartG mbB). He began his professional career in 2006 as a lawyer in the medical and health law department of an international law firm in Hamburg, from where he moved to the legal department of a research-based pharmaceutical company in 2007. Dr. Geiger’s last position there was as Senior Legal Counsel, Head of Governance Risk & Compliance and Compliance Officer. From 2009 – 2011, he was a member of the board of the Voluntary Self-Regulation of the Pharmaceutical Industry (FSA) e. V. Since 2012, he has been a member of the “Healthcare Compliance Advisory Board” of Arzneimittel und Kooperation im Gesundheitswesen (AKG) e. V. and since 2014 a member of the anti-corruption working group of the German Pharmaceutical Industry Association (BPI). Mr. Geiger is a lecturer for medical criminal law in the master’s degree program in medical law (LL.M.) at Dresden International University (DIU), lecturer for healthcare compliance in the master’s degree program “Pharmaceutical Law” (LL.M.) at Philipps University Marburg and at the School of Governance Risk & Compliance at Steinbeis University Berlin. Mr. Geiger is the author of numerous specialist publications in the fields of medical criminal law, healthcare compliance and pharmaceutical law.